445 related articles for article (PubMed ID: 17906452)
1. Current status in human breast cancer micrometastasis.
Alix-Panabières C; Müller V; Pantel K
Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
[TBL] [Abstract][Full Text] [Related]
2. Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
Pantel K; Müller V; Auer M; Nusser N; Harbeck N; Braun S
Clin Cancer Res; 2003 Dec; 9(17):6326-34. PubMed ID: 14695131
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells and bone marrow micrometastasis.
Alix-Panabières C; Riethdorf S; Pantel K
Clin Cancer Res; 2008 Aug; 14(16):5013-21. PubMed ID: 18698019
[TBL] [Abstract][Full Text] [Related]
4. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
5. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
Lang JE; Hall CS; Singh B; Lucci A
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
[TBL] [Abstract][Full Text] [Related]
6. BM micrometastases and circulating tumor cells in breast cancer patients: where have we been, where are we now and where does the future lie?
Müller V; Pantel K
Cytotherapy; 2005; 7(6):478-82. PubMed ID: 16306009
[TBL] [Abstract][Full Text] [Related]
7. Micrometastasis in breast cancer and other solid tumors.
Pantel K; Woelfle U
J Biol Regul Homeost Agents; 2004; 18(2):120-5. PubMed ID: 15471214
[TBL] [Abstract][Full Text] [Related]
8. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
9. Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients.
Becker S; Solomayer E; Becker-Pergola G; Wallwiener D; Fehm T
Breast Cancer Res Treat; 2007 Dec; 106(2):239-43. PubMed ID: 17260094
[TBL] [Abstract][Full Text] [Related]
10. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
Pierga JY; Bidard FC; Mathiot C; Brain E; Delaloge S; Giachetti S; de Cremoux P; Salmon R; Vincent-Salomon A; Marty M
Clin Cancer Res; 2008 Nov; 14(21):7004-10. PubMed ID: 18980996
[TBL] [Abstract][Full Text] [Related]
12. Circulating and disseminated tumor cells in the management of breast cancer.
Ross JS; Slodkowska EA
Am J Clin Pathol; 2009 Aug; 132(2):237-45. PubMed ID: 19605818
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells as prognostic marker in metastatic breast cancer.
Andreopoulou E; Cristofanilli M
Expert Rev Anticancer Ther; 2010 Feb; 10(2):171-7. PubMed ID: 20131993
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells in breast cancer.
Ignatiadis M; Georgoulias V; Mavroudis D
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
[TBL] [Abstract][Full Text] [Related]
15. Disseminated tumor cells in breast cancer: detection, characterization and clinical relevance.
Wölfle U; Müller V; Pantel K
Future Oncol; 2006 Aug; 2(4):553-61. PubMed ID: 16922621
[TBL] [Abstract][Full Text] [Related]
16. The direct molecular analysis of metastatic precursor cells in breast cancer: a chance for a better understanding of metastasis and for personalised medicine.
Klein CA
Eur J Cancer; 2008 Dec; 44(18):2721-5. PubMed ID: 19022661
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients.
Bartkowiak K; Effenberger KE; Harder S; Andreas A; Buck F; Peter-Katalinic J; Pantel K; Brandt BH
J Proteome Res; 2010 Jun; 9(6):3158-68. PubMed ID: 20423148
[TBL] [Abstract][Full Text] [Related]
18. Occult micrometastasis: enrichment, identification and characterization of single disseminated tumour cells.
Pantel K; Otte M
Semin Cancer Biol; 2001 Oct; 11(5):327-37. PubMed ID: 11562175
[TBL] [Abstract][Full Text] [Related]
19. Micrometastatic disease in breast cancer: clinical implications.
Ignatiadis M; Georgoulias V; Mavroudis D
Eur J Cancer; 2008 Dec; 44(18):2726-36. PubMed ID: 19056036
[TBL] [Abstract][Full Text] [Related]
20. [Minimal residual disease in breast cancer: detection and clinical relevance].
Pantel K; Wölfle U
Verh Dtsch Ges Pathol; 2005; 89():68-75. PubMed ID: 18035675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
